AIM2 and Alzheimer disease: The deletion of AIM2 in microglia has been demonstrated to improve cognitive impairment and synaptic deficits in an Aβ1-42-induced AD mouse model, suggesting the activation of microglia-mediated by AIM2 contributes to the inflammasome-mediated neuroinflammatory processes seen in AD [40].